<--- Back to Details
First PageDocument Content
Drug rehabilitation / Euphoriants / Morphinans / Drug addiction / Substance abuse / Methadone / Buprenorphine / Opioid replacement therapy / Drug policy / Chemistry / Ethics / Organic chemistry
Date: 2007-05-06 10:59:33
Drug rehabilitation
Euphoriants
Morphinans
Drug addiction
Substance abuse
Methadone
Buprenorphine
Opioid replacement therapy
Drug policy
Chemistry
Ethics
Organic chemistry

doi:

Add to Reading List

Source URL: www.akzept.org

Download Document from Source Website

File Size: 81,61 KB

Share Document on Facebook

Similar Documents

Microsoft Word - VLD Packet.FINAL

Microsoft Word - VLD Packet.FINAL

DocID: 1rubZ - View Document

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

DocID: 1rtjz - View Document

TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

Sunil Bhonsle  Mar 2015 Corporate Presentation

Sunil Bhonsle Mar 2015 Corporate Presentation

DocID: 1rrwl - View Document

Adapt v13_doc revised

Adapt v13_doc revised

DocID: 1rrqr - View Document